keyword
https://read.qxmd.com/read/37798427/pan-tissue-mitochondrial-phenotyping-reveals-lower-oxphos-expression-and-function-across-cancer-types
#1
JOURNAL ARTICLE
Ilya N Boykov, McLane M Montgomery, James T Hagen, Raphael T Aruleba, Kelsey L McLaughlin, Hannah S Coalson, Margaret A Nelson, Andrea S Pereyra, Jessica M Ellis, Tonya N Zeczycki, Nasreen A Vohra, Su-Fern Tan, Myles C Cabot, Kelsey H Fisher-Wellman
Targeting mitochondrial oxidative phosphorylation (OXPHOS) to treat cancer has been hampered due to serious side-effects potentially arising from the inability to discriminate between non-cancerous and cancerous mitochondria. Herein, comprehensive mitochondrial phenotyping was leveraged to define both the composition and function of OXPHOS across various murine cancers and compared to both matched normal tissues and other organs. When compared to both matched normal tissues, as well as high OXPHOS reliant organs like heart, intrinsic expression of the OXPHOS complexes, as well as OXPHOS flux were discovered to be consistently lower across distinct cancer types...
October 5, 2023: Scientific Reports
https://read.qxmd.com/read/35756609/bioenergetic-phenotyping-of-den-induced-hepatocellular-carcinoma-reveals-a-link-between-adenylate-kinase-isoform-expression-and-reduced-complex-i-supported-respiration
#2
JOURNAL ARTICLE
Kelsey L McLaughlin, Margaret A M Nelson, Hannah S Coalson, James T Hagen, McLane M Montgomery, Ashley R Wooten, Tonya N Zeczycki, Nasreen A Vohra, Kelsey H Fisher-Wellman
Hepatocellular carcinoma (HCC) is the most common form of liver cancer worldwide. Increasing evidence suggests that mitochondria play a central role in malignant metabolic reprogramming in HCC, which may promote disease progression. To comprehensively evaluate the mitochondrial phenotype present in HCC, we applied a recently developed diagnostic workflow that combines high-resolution respirometry, fluorometry, and mitochondrial-targeted nLC-MS/MS proteomics to cell culture (AML12 and Hepa 1-6 cells) and diethylnitrosamine (DEN)-induced mouse models of HCC...
2022: Frontiers in Oncology
https://read.qxmd.com/read/27160683/knowledge-attitudes-and-practices-regarding-epilepsy-in-the-kingdom-of-bhutan
#3
COMPARATIVE STUDY
Kate Brizzi, Sonam Deki, Lhab Tshering, Sarah J Clark, Damber K Nirola, Bryan N Patenaude, Erica D McKenzie, Hannah C McLane, Sydney S Cash, Chencho Dorji, Farrah J Mateen
OBJECTIVE: To assess the knowledge, attitudes and practices of epilepsy among healthcare workers (HCWs) and people with epilepsy (PWE) living in Bhutan. METHODS: A survey with similar questions was distributed to HCWs and PWE (2014-2015). Responses were compared between the two groups. A Stigma Scale in Epilepsy Score was tested for an independent association with patient age, sex, years of education and presence of seizure freedom using regression models. RESULTS: PWE (n=177), when compared to HCWs (n=75), were more likely to believe that epilepsy is contagious; epilepsy results from karma or past actions; PWE need help in school; and people with epilepsy have spiritual powers (p<0...
July 2016: International Health
https://read.qxmd.com/read/26446063/availability-accessibility-and-affordability-of-neurodiagnostic-tests-in-37-countries
#4
JOURNAL ARTICLE
Hannah C McLane, Aaron L Berkowitz, Bryan N Patenaude, Erica D McKenzie, Emma Wolper, Sarah Wahlster, Günther Fink, Farrah J Mateen
OBJECTIVE: To determine the availability, accessibility, and affordability of EEG, EMG, CSF analysis, head CT, and brain MRI for neurologic disorders across countries. METHODS: An online, 60-question survey was distributed to neurology practitioners in 2014 to assess the presence, wait time, and cost of each test in private and public health sectors. Data were stratified by World Bank country income group. Affordability was calculated with reference to the World Health Organization's definition of catastrophic health expenditure as health-related out-of-pocket expenditure of >40% of disposable household income, and assessment of providers' perceptions of affordability to the patient...
November 3, 2015: Neurology
https://read.qxmd.com/read/24207029/worldwide-reported-use-of-iv-tissue-plasminogen-activator-for-acute-ischemic-stroke
#5
JOURNAL ARTICLE
Aaron L Berkowitz, Manoj K Mittal, Hannah C McLane, Gordon C Shen, Rajanandini Muralidharan, Jennifer L Lyons, Russell T Shinohara, Ashfaq Shuaib, Farrah J Mateen
BACKGROUND AND PURPOSE: Intravenous tissue plasminogen activator is the most effective treatment for acute ischemic stroke, and its use may therefore serve as an indicator of the available level of acute stroke care. The greatest burden of stroke is in low- and middle-income countries, but the extent to which intravenous tissue plasminogen activator is used in these countries is unreported. SUMMARY OF REVIEW: A systematic review was performed searching each country name AND 'stroke' OR 'tissue plasminogen activator' OR 'thrombolysis' using PubMed, Embase, Global Health, African Index Medicus, and abstracts published in the International Journal of Stroke (Jan...
April 2014: International Journal of Stroke: Official Journal of the International Stroke Society
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.